CHILI 4.0

Conference on Hybrid Imaging Live

October 29, 2021 | 08:30 CEST

REGISTER NOW

Join colleagues from more than 100 countries and register for free!


CHILI – the Conference on Hybrid Imaging Live – will return with its engaging format on October 29, 2021. A full day of hybrid imaging awaits you with a clear focus how hybrid imaging can guide clinical therapy in a multitude of clinical applications in oncology, infection and inflammation. It will again be streamed online only and will be free of charge for everyone.

A professional studio, live moderation and live speakers will make CHILI stand out from other online conferences with pre-recorded talks from the can. CHILI is live, CHILI is fresh, CHILI is spicy.

CME accreditation

CHILI – Conference on Hybrid Imaging Live (CME – 2769), has been accredited by the Accreditation Council of Oncology in Europe (ACOE) with 7 European CME Credits.

ACOE is one of the four of the European Specialty Accreditation Boards (ESABs) recognised by the European Union of Medical Specialists (UEMS). CME Accreditation Approval by ACOE means that the programme has been recognised of high-quality value both from a scientific and didactic point of view.


INTRODUCTION

08:25-08:30

Introduction to CHILI 4.0
Clemens Cyran, Munich /DE


NEW HORIZONS FOR HYBRID IMAGING

08:30-08:55

Total body PET/CT - key benefits and applications
Thomas Beyer, Vienna /AT

08:55-09:20

AI in multimodality hybrid imaging
Irène Buvat, Orsay /FR

09:20-09:45

Novel molecular imaging probes for oncologic imaging and what's their translational potential
Andrew Scott, Melbourne /AUS

09:45-10:15

Round table discussion:
The prospects of clinical implementation for new modalities, probes and algorithms on the horizon.

10:15-10:30

Break

 

ONCOLOGY 1: HYBRID IMAGING AS THE STANDARD OF CARE

10:30-10:50

PET/CT in lymphoma - the standard of clinical care
Marius Mayerhöfer, New York / USA

10:50-11:10

Lung carcinoma - the challenges in staging and therapy monitoring
tba

11:10-11:30

Why PET/CT in HNSCC?
Andy Scarsbrook, Leeds /UK

11:30-11:50

Melanoma: Imaging-based therapeutic management
Marcus Unterrainer, Munich /DE

11:50-12:15

Discussion and Q&A with the experts

12:15-12:30

Break

 

12:30-13:15

SPONSORED SYMPOSIUM & DISCUSSION

13:15-13:30

Break

 

ONCOLOGY 2: THE WORLD BEYOND FDG

13:30-13:50

Neuroendocrine tumors: Therapeutic management with SSR-targeting tracers
Clemens Cyran, Munich /DE

13:50-14:10

Prostate carcinoma: PSMA PET/CT in clinical decision guidance
tba

14:10-14:30

FAPI PET: the new FDG in solid tumors?
tba

14:30-14:50

FET PET/MRI in neuro-oncology
Jiří Ferda, Plzeň /CZ

14:50-15:15

Discussion and Q&A with the experts

15:15-15:30

Break

 

15:30-16:00

SPONSORED SYMPOSIUM & DISCUSSION

16:00-16:15

Break

 

INFECTION AND INFLAMMATION

16:15-16:35

Rheumatological diseases: The role of hybrid imaging
Mona-Elisabeth Revheim, Oslo /NO

16:35-16:55

Prothesis infection - from aortic replacements to endoprothesis
Michel Eisenblätter, Freiburg /DE

16:55-17:15

Specific tracers in imaging of inflammation
José Vercher-Conejero, Barcelona /ES

17:15-17:35

Hybrid imaging in COVID-19: What have we learned?
Manil Subesinghe, London /UK

17:35-18:00

Discussion and Q&A with the experts

Moderators

Moderator

Clemens C. Cyran

München, Germany

Speakers

Presenter

Thomas Beyer

Vienna, Austria

Presenter

Irène Buvat

Orsay, France

Presenter

Andrew Scott

Melbourne, Australia

Presenter

Marius E. Mayerhöfer

Wien, Austria

Presenter

Andrew Scarsbrook

Leeds, United Kingdom

Presenter

Marcus Unterrainer

Munich, Germany

Presenter

Jirí Ferda

Plzen, Czechia

Presenter

Mona-Elisabeth Revheim

Vettre, Norway

Presenter

Michel Eisenblätter

Freiburg, Germany

Presenter

José L. Vercher-Conejero

Barcelona, Spain